Dosing differences between valproic acid concentrate and divalproex sodium: a case report
Coffey, G.; Botts, S.; de Leon, J.
Journal of Clinical Psychiatry 65(5): 724-725
2004
ISSN/ISBN: 0160-6689 PMID: 15163266 Document Number: 571346
Document emailed within 1 workday
Related Documents
Mnif, L.; Sellami, R.; Masmoudi, J. 2016: Valproic Acid and Hepatic Steatosis: A Possible Link? About a Case Report Psychopharmacology Bulletin 46(2): 59-62Suntimaleeworakul, W.; Patharachayakul, S.; Chusri, S. 2012: Drug interaction between valproic acid and meropenem: a case report Journal of the Medical Association of Thailand 95(2): 293-295
Baskies, A.M. 1984: Case report: pancreatic pseudocyst associated with valproic acid therapy Journal of the Medical Society of New Jersey 81(5): 399-400
Sorel, L.; Rucquoy-Ponsar, M.; Willems, C.; Diepart, E.; Harmant, J. 1981: Comparative study of valproic acid and sodium valproate Acta Neurologica Belgica 81(5): 283-290
Horne, M.; Lindley, S.E. 1995: Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes Journal of Clinical Psychiatry 56(9): 430-431
Bahamonde Carrasco, A.; Morán Blanco, A.; Olcoz Goñi, J.L. 1996: Acute pancreatitis caused by valproic acid: apropos a case Gastroenterologia y Hepatologia 19(5): 253-254
Patel, N.; Landry, K.B.; Fargason, R.E.; Birur, B. 2017: Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report Psychopharmacology Bulletin 47(1): 40-44
Porubek, D.J.; Grillo, M.P.; Baillie, T.A. 1989: The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(2): 123-130
Champel, V.; Radal, M.; Moulin-Vallez, M.; Jonville-Béra, A.P.; Autret-Leca, E. 1999: Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy Revue Neurologique (Paris) 155(3): 220-224
Liu, M.J.; Brouwer, K.L.; Pollack, G.M. 1992: Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 810-815
Ortega-García, Mía.Pilar.; Abril-López de Medrano, V.; Gimeno-Cardona, Cón. 2016: Changes in the dosing of colistimethate sodium in critically ill patients Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 29(1): 53-54
Kohda, Y. 1995: Valproic acid Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 918-920
Stanosz, S.; Wysoczański, E. 1970: Studies of the effects of sodium salt of 2,4-dichlorophenoxyacetic acid (Pielik) and sodium salt of 2-methyl-4-chlorophenoxyacetic acid (Chwostaks) on the sexual cycle in white rats Endokrynologia Polska 21(6): 585-591
Waring, E.W.; Dewan, V.K.; Cohen, D.; Grewal, R. 1999: Risperidone as an adjunct to valproic acid Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(2): 189
Gedan, A.; Kleemann, V.; Pfeifer, S. 1984: Hydrolysis of valproamide to valproic acid Die Pharmazie 39(12): 865
Borchert, H.H.; Schuster, S.; Pfeifer, S. 1980: Metabolic interaction of valproic acid Die Pharmazie 34(5-6): 313-314
Klotz, U. 1977: Pharmacokinetic studies with valproic acid in man Arzneimittel-Forschung 27(5): 1085-1088
Kohda, Y. 1990: Therapeutic drug monitoring of valproic acid Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1130-1133
Vajda, F.J. 1983: Valproic acid in the treatment of status epilepticus Advances in Neurology 34: 519-529
Bruni, J.; Wilder, B.J.; Willmore, L.J.; Barbour, B. 1979: Valproic acid and plasma levels of phenytoin Neurology 29(6): 904-905